Ticker League

Shares Outstanding for DexCom (DXCM)

As of · Reported

Metric

Latest period

393.60M

YoY change

-1.7%

5Y CAGR

+0.8%

Peak year (2021)

428.80M

Shares Outstanding history chart for DexCom (DXCM) from 2000 to 2025

Latest: 405.50M

Shares Outstanding growth chart for DexCom (DXCM) from 2000 to 2025

Latest: -1.7%

Shares Outstanding history table for DexCom (DXCM) from 2000 to 2025

  • 2025405.50M-1.7%
  • 2024412.70M-3.0%
  • 2023425.50M-0.5%
  • 2022427.50M-0.3%
  • 2021428.80M+9.9%
  • 2020390.00M+5.6%
  • 2019369.20M+4.6%
  • 2018352.80M+2.2%
  • 2017345.20M+3.2%
  • 2016334.40M+4.8%
  • 2015319.20M+6.1%
  • 2014300.80M+5.8%
  • 2013284.40M+3.5%
  • 2012274.80M+4.7%
  • 2011262.40M+15.3%
  • 2010227.60M+28.3%
  • 2009177.39M+50.4%
  • 2008117.95M+4.1%
  • 2007113.25M+4.0%
  • 2006108.94M+43.8%
  • 200575.78M+728.7%
  • 20049.14M+5.3%
  • 20038.68M+6.0%
  • 20028.18M+7.9%
  • 20017.59M+9.8%
  • 20006.91M—

Shares Outstanding values are taken from DexCom's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Shares Outstanding at DexCom (DXCM)

According to DexCom's latest reported financial statements, the company's latest reported diluted shares outstanding is 393.60M. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

The 2025 reading of DexCom (DXCM) diluted shares outstanding is 405.50M – edged down 1.7% year-over-year.

Across 2020–2025 (5 years), DexCom diluted shares outstanding produced a CAGR of +0.8% – with mixed annual results across the window.

DexCom diluted shares outstanding declined from 428.80M in 2021 to 405.50M in 2025, a 5.4% drawdown.

2021 marks the peak diluted shares outstanding at 428.80M, with the historical low of 6.91M recorded in 2000.

DexCom Shares Outstanding by Year

DexCom Shares Outstanding 2025: 405.50M

DexCom diluted shares outstanding in 2025 was 405.50M, edged down 1.7% below 2024.

DexCom Shares Outstanding 2024: 412.70M

2024's diluted shares outstanding for DexCom came in at 412.70M, edged down 3.0% below 2023.

DexCom Shares Outstanding 2023: 425.50M

DexCom posted diluted shares outstanding of 425.50M in 2023, edged down 0.5% below 2022.

DexCom Shares Outstanding 2022: 427.50M

In 2022, DexCom reported diluted shares outstanding of 427.50M, edged down 0.3% below 2021.

DexCom Shares Outstanding 2021: 428.80M

DexCom diluted shares outstanding in 2021 was 428.80M.

See more financial history for DexCom (DXCM).

Sector peers by Shares Outstanding

Healthcare peers of DexCom (DXCM), ranked by their latest diluted shares outstanding

Frequently asked questions

DexCom (DXCM) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation